Thomas James Gunderson - Jun 17, 2021 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 07:11 PM
Previous filing
Jun 1, 2021
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +2.91K +69.58% $0.00 7.1K Jun 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MMSI Non-qualified stock options (right to buy) 25K Jun 17, 2021 Common Stock 25K $34.40 Direct F2
holding MMSI Non-qualified stock options (right to buy) 25K Jun 17, 2021 Common Stock 25K $50.50 Direct F3
holding MMSI Non-qualified stock options (right to buy) 13.8K Jun 17, 2021 Common Stock 13.8K $52.17 Direct F4
holding MMSI Non-qualified stock options (right to buy) 7.5K Jun 17, 2021 Common Stock 7.5K $52.17 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022 and 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date.
F2 Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
F3 Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
F4 Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
F5 Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.